Paul L. Hallenbeck

Statistics

Publications

Citations

3.2K

H-Index

Active since

1987

Affiliations

Research Institute for Genetic and Human Therapy(Current)

Novartis (United States)

Scripps Research Institute

National Institutes of Health

Baylor College of Medicine

Paul L. Hallenbeck is an author at Research Institute for Genetic and Human Therapy specializing in life sciences, molecular biology, and molecular virology.

Publications per year

1987–2013

Publications

H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes.

Michael S. Marks, Paul L. Hallenbeck, Toshi Nagata et al. · The EMBO Journal · 1992 · 475 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus

Laura M. Hales, Nick J. Knowles, P. Seshidar Reddy et al. · Journal of General Virology · 2008 · 382 citations

Life Sciences, Biology, Molecular Biology +17

A Novel Tumor-Specific Replication-Restricted Adenoviral Vector for Gene Therapy of Hepatocellular Carcinoma

Paul L. Hallenbeck, Doug Golightly, David A. Stewart et al. · Human Gene Therapy · 1999 · 283 citations

Life Sciences, Biotechnology, Oncology +14

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

P. Seshidhar Reddy, Kevin D. Burroughs, Laura M. Hales et al. · JNCI Journal of the National Cancer Institute · 2007 · 253 citations · Full text

Life Sciences, Infectious Diseases, Oncology +16

Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.

Shuichi Kaneko, Paul L. Hallenbeck, Takenori Kotani et al. · PubMed · 1995 · 177 citations

Life Sciences, Molecular Biology, Oncology +14

1–5 of 25